Meet the Founder

Meet the founder at Rewrite Biology

 

About the Founder


Diego is the founder of Rewrite Biology, an independent initiative born out of deep curiosity, personal experience, and a relentless pursuit of answers to some of medicine’s most complex questions.


With no formal background in medicine or science, Diego took a different path—one grounded in logic, observation, and a systems-level approach to human biology. Over the past seven years, he’s conducted independent research that challenges conventional thinking about aging and disease progression.


He believes that science isn’t limited to institutions or degrees. Every human body is a living case study. When we pay close attention—when we question, observe, and connect patterns—we can uncover insights that traditional methods sometimes overlook.


Diego’s work is driven by the idea that many diseases give visible, physical, and functional signs long before they are diagnosed. By reinterpreting these early clues, he believes we can not only treat, but prevent disease more effectively—ushering in a new chapter in medicine, diagnostics, and longevity.


Rewrite Biology represents the belief that breakthrough ideas can come from outside the system—and that collaboration between unconventional thinkers and established institutions can transform what’s possible in human health.


Popular posts from this blog

Has the AI Drug Discovery Hype Train Derailed? A Reality Check for Pharma and Biotech

Image
When smarter algorithms hit the wall of outdated biology In 2021, venture capitalists poured over $2 billion into AI-powered drug discovery startups. The hope was clear: artificial intelligence could compress a 10-year, multi-billion-dollar R&D cycle into a few years and a few million dollars. Companies like Recursion , Exscientia , and Insilico Medicine emerged as poster children for this new era, promising a revolution that would change the trajectory of pharmaceutical research forever. But fast forward to 2025, and the story looks much different. Stock prices are down. Investors are wary. M&A activity is heating up—not because of success, but because of pressure to survive. What happened? ⸻ 💡 AI Was a Tool, Not a Cure AI drug discovery promised efficiency: faster molecule generation, better hit prediction, and streamlined clinical trial design. In some areas—like protein structure prediction (e.g., AlphaFold)—it delivered. But the ...
Read more

Rewriting the Rules of Disease.

Image
Logic-driven, independent research that questions everything. Modern medicine has built its house on shaky ground. While the world waits for AI and billion-dollar labs to deliver miracles, one researcher took a different path—using logic, pattern recognition, and trial-and-error to uncover what science has overlooked. RewriteBiology  is a movement to rethink how we understand illness, aging, and the immune system itself. What if the root causes of chronic disease aren’t genetic or lifestyle-based—but microbial, slow-moving, and hiding in plain sight? What if menopause isn’t just a phase—but the tipping point of immune system collapse? This project challenges the status quo with new theories, real-world experimentation, and a commitment to truth over tradition. The goal is simple: uncover what’s been missed—and change medicine forever.
Read more

The Menopause Breakthrough: A New Biology to End Chronic Disease

Image
By RewriteBiology “What if everything we thought we knew about aging, menopause, and disease was wrong—and the key to preventing Alzheimer’s, diabetes, and heart disease was hiding in plain sight?” Why I Wrote This As a self-taught researcher, I've spent years studying the patterns of disease and blind spots in modern medicine. What I found was surprising: many chronic illnesses may stem from a misunderstood biological shift— menopause , in both men and women. This isn’t just about hormones. It’s about how a midlife shift marks the tipping point where pathogens overwhelm the immune system—leading to aging, neurological decline, and nearly all chronic diseases . From Crisis to Breakthrough Pharma is evolving, but current strategies still treat symptoms—not causes. What if Alzheimer’s , diabetes , and cancer all stem from the same failure in regeneration and immune control? What if it all starts around menopause? Menopause: The Overlooked Turning Point RewriteBiology r...
Read more